Atossa Therapeutics ATOS
NASDAQ ATOS
$2.27 +0.32 (+16.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Current Debt (2012)

Updated

Atossa Therapeutics (ATOS) reported Current Debt of -$250,000 for Q4 2012.

Analysis

Atossa Therapeutics (ATOS) Current Debt (2012) Analysis & Trends

For FY2012, Atossa Therapeutics posted Current Debt of -$1 million.

  • By year, Current Debt came in at $1 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 37.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Atossa Therapeutics 19.46 Mn 19.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -250,000.00
Mar 31, 2012 -750,000.00
API Access

Atossa Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ATOS&period=max&api_key=YOUR_API_KEY